Enanta Pharmaceuticals (ENTA) Current Deferred Tax Assets (2014 - 2016)

Enanta Pharmaceuticals has reported Current Deferred Tax Assets for 3 years, with the latest figure at $1.1 million in Q2 2016.

• For the quarter ending Q2 2016, Current Deferred Tax Assets fell 34.72% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2016 stood at $1.1 million (down 34.72% YoY), and the FY2015 full-year result was $1.4 million, down 86.99% from the prior year.
• Current Deferred Tax Assets for Q2 2016 stood at $1.1 million, down from $1.6 million in the prior quarter.
• The five-year high for Current Deferred Tax Assets was $11.2 million in Q2 2014, with the low at $1.1 million in Q2 2016.
• Historically, Current Deferred Tax Assets has averaged $3.6 million across 3 years, with a median of $1.6 million in 2015.
• The largest YoY upside for Current Deferred Tax Assets was 17.28% in 2015 against a maximum downside of 86.99% in 2015.
• Enanta Pharmaceuticals' Current Deferred Tax Assets stood at $1.3 million in 2014, then gained by 17.28% to $1.6 million in 2015, then dropped by 27.45% to $1.1 million in 2016.
• The last three Current Deferred Tax Assets figures came in at $1.1 million (Q2 2016), $1.6 million (Q1 2016), and $1.6 million (Q4 2015), per Business Quant data.